EVEXIA PRACTICE SUPPORT INFO CENTER
Welcome to the Evexia Diagnostics COVID-19 Repository Page. While the global health crisis concerning the SARS-CoV-2 pandemic continues to unfold, Evexia’s focus and commitment to offering high-quality, state-of-the-art testing at affordable prices is becoming increasingly vital. Our current goal is to increase the availability of fast and reliable COVID-19 testing to help mitigate the current spread of the virus. We also recognize that there is a severe shortage of these testing options, as well as a lack of proper guidance on what testing is most appropriate. As a result, we have created this resource dedicated to providing easy access to insightful information, cost-effective and reliable testing options, as well as recommendations for nutraceutical support.
Evexia Diagnostics remains ready to support your practice and the needs of your patients. Please contact us and let us know how we can assist you in providing the necessary support for your practice.
JUNE 4, 2020 -3:00 P.M.
MAY 7, 2020 - 2:00 P.M.
Evexia Diagnostics is excited to expand our current COVID-19 test offerings to now include a new COVID-19 Antibody A La Carte option. This cost-effective and flexible solution provides testing for individual IgA, IgG, and IgM immunoglobulins or any combination that best suits the needs of your patients. Another added convenience feature is that the IgG option can be collected at over 2000 Patient Service Centers (PSCs) across the country. The IgA and IgM analytes, however, must be collected in office or at the patient’s home through a mobile phlebotomy service. Contact us today to learn more and place your order!
Please be aware that due to supply constraints we are not able to offer the nasopharyngeal PCR test until further notice. However, the nasal swab PCR option is still available for order.
APRIL 2, 2020 - 2:00 P.M.
Evexia Diagnostics is pleased to announce the launch of the new COVID-19 PCR Stool Test, which is now available to all Evexia clients! The new COVID-19 PCR Stool Test utilizes a cutting-edge viral RNA qPCR methodology to detect and measure levels of SARS-CoV-2 virus in stool. The new COVID-19 PCR Stool Test, can be an important clinical tool for clinicians who are monitoring confirmed SARS-CoV-2 patients in order to help prevent transmission of the SARS-CoV-2 virus.
COVID-19 PCR Stool Testing
Recent studies have demonstrated that SARS-CoV-2 in the stool may be found in up to 53.4% of COVID-19 patients and can be detected in the stool for a period of days to weeks after the initial infection. Emerging evidence also shows that an intestinal viral infection may play an important role in COVID-19 disease progression and may increase the risk of more severe disease.
This test is important because the detection of SARS-CoV-2 in the stool could be used to prevent fecal-oral transmission.
Please note that the SARS-CoV-2 Stool Analysis is not diagnostic of COVID-19. COVID-19 can only be properly diagnosed and confirmed using the nasopharyngeal COVID-19 PCR Test.
COVID-19 TESTING GUIDANCE
COVID-19 TESTING INTERACTIVE GUIDE
To find the COVID-19 testing that is right for your patients:
1. Review the 3 questions to the right and click on the one that applies to your patient.
2. Continue to answer the Yes and No questions until you are supplied with the proper COVID-19 test that is is optimal for your patient.
3. Click on the answer to be taken to the proper testing where you may learn more and begin ordering.
We also provide this helpful testing guidance information in a convenient pdf document, click here to view or download.